Laboratory of Molecular Virology, Foundation Polyclinic Tor Vergata, Viale Oxford, Rome, Italy.
J Med Virol. 2013 Jun;85(6):1122-4. doi: 10.1002/jmv.23565.
Primary infection with KIPyV and WUPyV polyomaviruses occurs early in childhood followed by lifelong persistence in the body. Polyomavirus reactivation can occur in the presence of impaired immunity as in hematological malignancies or during immunosuppresssion induced by medications. In this study, reactivation of KIPyV and WUPyV was monitored by conventional PCR in plasma samples of 26 stem cell transplant patients and in 26 related bone marrow donors. Plasma samples from transplant patients were collected immediately after the end of conditioning regimen and up to 270 days after transplant. All plasma samples from transplant patients were negative for KIPyV and WUPyV DNA. Instead, KIPyV DNA was detected in two bone marrow donors. There was no evidence of KIPyV transmission from the donor to the recipient. The data suggest that detection of KIPyV in plasma is sporadic and that KPIyV and WUPyV do not affect the post-transplant clinical course. However, further studies on a larger sample size and more sensitive PCR methods are needed to confirm these observations.
原发性 KIPyV 和 WUPyV 多瘤病毒感染发生在儿童早期,随后在体内持续存在终生。多瘤病毒的重新激活可能发生在免疫功能受损的情况下,如血液恶性肿瘤,或在药物诱导的免疫抑制下。在这项研究中,通过常规 PCR 监测 26 例干细胞移植患者和 26 例相关骨髓供体的血浆样本中的 KIPyV 和 WUPyV 的重新激活。移植患者的血浆样本在预处理方案结束后立即采集,并在移植后 270 天内采集。所有移植患者的血浆样本均为 KIPyV 和 WUPyV DNA 阴性。相反,在两名骨髓供体中检测到了 KIPyV DNA。没有证据表明供体向受体传播 KIPyV。这些数据表明,血浆中 KIPyV 的检测是散发性的,KPIyV 和 WUPyV 不会影响移植后的临床过程。然而,需要进一步的研究,包括更大的样本量和更敏感的 PCR 方法,以证实这些观察结果。